Darzalex

Made by

• Janssen Pharmaceutical

Active Ingredient

Daratumumab (genetical recombination)

Approval date

2017/9/27

Treats

• Multiple myeloma

Dosages

• DARZALEX Intravenous Infusion - 52262円／瓶

• DARZALEX Intravenous Infusion - 187970円／瓶